Trial Profile
A pilot study to determine the effects of short-term thiazolidinedione [rosiglitazone, pioglitazone] treatment on vascular risk markers in type 2 diabetes patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Rosiglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 02 Jan 2008 New trial record.